Qurient Co., Ltd.
Clinical-stage biopharma developing drugs for oncology, cGvHD, and tuberculosis.
115180 | KO
Overview
Corporate Details
- ISIN(s):
- KR7115180002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 242, C동 8층, 성남시
- Website:
- http://www.qurient.com/
Description
Qurient Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for unmet medical needs. The company operates on a proprietary 'Network R&D' model, a virtual approach that manages drug development programs from early discovery through clinical phases. Its pipeline includes Adrixetinib for chronic graft-versus-host disease (cGvHD), Telacebec for the treatment of tuberculosis, and a next-generation dual-payload Antibody-Drug Conjugate (ADC) platform for oncology. Qurient advances its portfolio through global clinical trials and strategic collaborations to address critical diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-21 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정)(항암치료제 Q901 단독요법 및 펨브롤리주맙(키트루다)과의 병용요법에 대한 식품의약품안전처(…
|
Korean | 12.8 KB | ||
| 2023-06-08 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.3 KB | ||
| 2023-05-12 00:00 |
분기보고서 (2023.03)
|
Korean | 976.1 KB | ||
| 2023-04-28 00:00 |
소속부변경
|
Korean | 3.6 KB | ||
| 2023-04-03 00:00 |
투자판단관련주요경영사항(항암치료제 Q901 단독요법 및 펨브롤리주맙(키트루다)과의 병용요법에 대한 식품의약품안전처(MFDS) 임상 제1/2상 …
|
Korean | 10.9 KB | ||
| 2023-03-31 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.2 KB | ||
| 2023-03-27 00:00 |
정기주주총회결과
|
Korean | 30.3 KB | ||
| 2023-03-27 00:00 |
주식매수선택권부여에관한신고
|
Korean | 17.6 KB | ||
| 2023-03-27 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 32.8 KB | ||
| 2023-03-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2023-03-17 00:00 |
감사보고서제출
|
Korean | 24.6 KB | ||
| 2023-03-17 00:00 |
사업보고서 (2022.12)
|
Korean | 1.4 MB | ||
| 2023-03-16 00:00 |
[기재정정]주주총회소집결의
|
Korean | 20.7 KB | ||
| 2023-03-10 00:00 |
주주총회소집결의
|
Korean | 17.6 KB | ||
| 2023-03-10 00:00 |
주주총회소집공고
|
Korean | 176.4 KB |
Automate Your Workflow. Get a real-time feed of all Qurient Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Qurient Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Qurient Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
